H. Lee Moffitt Cancer Center and Research Institute: all 539 studies
Page 6 of 6. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.
- Pharmacogenomic Study of Docetaxel and Cisplatin, Followed by Docetaxel, Cisplatin and Irradiation.TerminatedNCT00216008Phase 2
- Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasCompletedNCT00215995Phase 2
- Study of Capecitabine With Irinotecan and Oxaliplatin (Eloxatin) in Advanced Colorectal CancerCompletedNCT00215982Phase 2
- A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal CarcinomaCompletedNCT00215956Phase 1
- Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerCompletedNCT00100906Phase 2
- Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00049218Phase 1/2
- Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical ProstatectomyCompletedNCT00042731Not applicable
- Isoflavones in Treating Women Who Have Breast Cancer and Are Planning to Undergo Mastectomy or LumpectomyTerminatedNCT00036686Not applicable
- Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2CompletedNCT00031564Phase 2
- Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple MyelomaCompletedNCT00012350Phase 2
- R115777 in Treating Patients With Advanced Bladder CancerCompletedNCT00006376Phase 2
- Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaCompletedNCT00006373Phase 2
- A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate CancerTerminatedNCT00006371Phase 2
- ERA-923 in Treating Postmenopausal Women With Metastatic Breast CancerStatus unknownNCT00006369Phase 2
- Arsenic Trioxide for Induction Therapy of Adult Patients With LeukemiaTerminatedNCT00006092Phase 2
- Vinorelbine in Treating Patients With Metastatic or Advanced Solid TumorsStatus unknownNCT00006088Phase 1
- BMS-188797 and Carboplatin in Treating Patients With Advanced Nonhematologic CancerCompletedNCT00006086Phase 1
- CP-609,754 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00006085Phase 1
- Combination Therapy With Oral 9-Nitrocamptothecin & Oral EtoposideCompletedNCT00006047Phase 1
- Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV MelanomaStatus unknownNCT00006035Phase 1
- Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck CancerCompletedNCT00006033Phase 2
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerTerminatedNCT00006032Phase 2
- Comparison of Two Types of Biopsy in Patients With Breast LesionsCompletedNCT00006031Not applicable
- Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow TransplantTerminatedNCT00005852Phase 2
- Doxorubicin and Docetaxel in Treating Women With Stage III Breast CancerCompletedNCT00005800Phase 2
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast CancerCompletedNCT00005798Phase 2
- Bone Marrow Transplant in Treating Patients With Hematologic CancersCompletedNCT00005797Phase 2
- A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and EtoposideCompletedNCT00005793Phase 1/2
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaCompletedNCT00005792Phase 1
- Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationTerminatedNCT00005641Phase 2
- Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Treatment of Colorectal CancerCompletedNCT00005640Not applicable
- Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)CompletedNCT00005626Phase 2
- CI-994 in Treating Patients With Advanced MyelomaCompletedNCT00005624Phase 2
- Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic DisordersCompletedNCT00005622Phase 2
- Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-AlfaCompletedNCT00005615Phase 1/2
- Management of Metastatic Breast Cancer in Frail PatientsWithdrawnNCT00005614Phase 2
- Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00005613Phase 2
- Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial CancerTerminatedNCT00005612Phase 1/2
- BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TreatmentStatus unknownNCT00005611Phase 1
← H. Lee Moffitt Cancer Center and Research Institute overview and focus areas